{"key":"op_830_ES","page":{"url":"https://us-uk.bookimed.com/clinics/country=spain/procedure=lutetium-177-therapy/","procedure":{"id":830,"slug":"lutetium-177-therapy","name":"Lutetium-177 therapy","name_forms":{"plural":{"status":"missing","reason":"not_collected"},"genitive":{"status":"missing","reason":"not_collected"}},"type":"therapy","grammar_number":{"status":"missing","reason":"not_collected"},"parent_id":"oncology","family_attribute":{"status":"missing","reason":"not_collected"}},"country":{"id":34,"iso":"ES","name":"Spain"},"currency":"USD","data_date":"2026-10-01"},"pages":{"clinics_url":"https://us-uk.bookimed.com/clinics/country=spain/procedure=lutetium-177-therapy/","cost_url":"https://us-uk.bookimed.com/clinics/country=spain/procedure=lutetium-177-therapy/cost/","best_url":{"status":"missing","reason":"template not live"}},"price":{"from":7500,"to":11000,"avg":{"status":"missing","reason":"no_offers"},"us":{"from":42000,"to":54000},"uk":{"from":21000,"to":31000},"by_technique":[{"technique":"Lu-177 PSMA-617 (Lu-PSMA) radioligand therapy","technique_id":"lu-177-psma-617-radioligand","price_from":7500,"currency":"USD","source":"estimate","date":"2026-11-17"},{"technique":"Lu-177 DOTATATE peptide receptor radionuclide therapy","technique_id":"lu-177-dotatate-peptide","price_from":8500,"currency":"USD","source":"estimate","date":"2026-11-17"}],"by_city":[{"city":"Alicante","from":10500},{"city":"Madrid","from":9500},{"city":"Barcelona","from":7500}],"per_unit":{"status":"missing","reason":"not_collected"},"factors":{"status":"missing","reason":"not_collected"},"tiers":{"status":"missing","reason":"no_offers"},"comparison":[{"country_iso":"UA","from":10000,"to":17000},{"country_iso":"FR","from":18000,"to":26000},{"country_iso":"GB","from":21000,"to":31000},{"country_iso":"US","from":42000,"to":54000},{"country_iso":"IL","from":16000,"to":26000},{"country_iso":"TR","from":5000,"to":8800},{"country_iso":"MX","from":6500,"to":10500},{"country_iso":"DE","from":17000,"to":26000},{"country_iso":"CA","from":28000,"to":45000},{"country_iso":"AE","from":9000,"to":16000},{"country_iso":"TH","from":7000,"to":9500},{"country_iso":"PL","from":6500,"to":10500},{"country_iso":"KR","from":9000,"to":14000},{"country_iso":"CZ","from":9500,"to":14500},{"country_iso":"AT","from":18000,"to":30000},{"country_iso":"IT","from":9500,"to":14500},{"country_iso":"CN","from":6500,"to":13000},{"country_iso":"AU","from":21000,"to":31000},{"country_iso":"IN","from":3200,"to":5200},{"country_iso":"MY","from":6500,"to":10500},{"country_iso":"VN","from":9000,"to":14000},{"country_iso":"BR","from":16000,"to":26000}],"base_country":"US","base_is_fallback":false},"savings":{"pct":82,"variant":">=15%"},"package":{"included":{"status":"missing","reason":"no_offers"},"excluded":{"status":"missing","reason":"no_offers"},"extra_charges":{"status":"missing","reason":"not_collected"}},"clinics":{"count":3,"items":[{"id":78,"name":"Centro Médico Teknon","city":"Barcelona","rating":4.7,"reviews_count":498,"accreditations":["Joint Commission International","European Foundation for Quality Management","THE IMTJ MEDICAL TRAVEL AWARD WINNER IN 2019","Patient choice in Neurology","Patient choice in Neurosurgery","Patient choice for Epilepsy treatment","World's Best Hospitals 2021 by Newsweek"],"rank":1,"has_procedure":true,"why_ranked":"Specializes in Lutetium-177 therapy with a multidisciplinary team and JCI accreditation. Offers personalized treatment plans and has performed 1,100+ treatments.","bookimed_stats":{"status":"missing","reason":"not_published"},"procedure_description":{"status":"missing","reason":"not_collected"},"offers":{"status":"missing","reason":"no_offers"}},{"id":310,"name":"HOSPITAL UNIVERSITARIO HM MADRID","city":"Madrid","rating":4.7,"reviews_count":17,"accreditations":["European Foundation for Quality Management","TÜV AG Сompany Research & Investing Certificate","World's Best Hospitals 2021 by Newsweek"],"rank":2,"has_procedure":true,"why_ranked":{"status":"missing","reason":"not_collected"},"bookimed_stats":{"status":"missing","reason":"not_published"},"procedure_description":{"status":"missing","reason":"not_collected"},"offers":{"status":"missing","reason":"no_offers"}},{"id":953,"name":"GenesisCare Clinics","city":"Madrid","rating":{"status":"missing","reason":"not_collected"},"reviews_count":{"status":"missing","reason":"not_collected"},"accreditations":{"status":"missing","reason":"not_collected"},"rank":3,"has_procedure":true,"why_ranked":{"status":"missing","reason":"not_collected"},"bookimed_stats":{"status":"missing","reason":"not_published"},"procedure_description":{"status":"missing","reason":"not_collected"},"offers":{"status":"missing","reason":"no_offers"}}]},"doctors":{"count":{"status":"missing","reason":"not_collected"},"languages":{"status":"missing","reason":"not_collected"}},"cities":[{"id":441,"slug":"alicante","name":"Alicante","clinics_count":{"status":"missing","reason":"not_collected"},"price_from":10500,"profile":{"city_type":"Mediterranean port city in Spain","access":["Alicante Airport (ALC), 9 km from the city"],"sources":["https://en.wikipedia.org/wiki/Alicante","https://en.wikipedia.org/wiki/Alicante%E2%80%93Elche_Airport"],"checked_at":"2026-11-03","status":"ok"}},{"id":346,"slug":"madrid","name":"Madrid","clinics_count":{"status":"missing","reason":"not_collected"},"price_from":9500,"profile":{"city_type":"Capital and largest city of Spain","access":["Madrid Barajas Airport (MAD), 13 km from Puerta del Sol"],"sources":["https://en.wikipedia.org/wiki/Madrid","https://en.wikipedia.org/wiki/Madrid–Barajas_Airport"],"checked_at":"2026-11-03","status":"ok"}},{"id":98,"slug":"barcelona","name":"Barcelona","clinics_count":{"status":"missing","reason":"not_collected"},"price_from":7500,"profile":{"city_type":"Mediterranean coastal city in Spain","access":["Barcelona Airport (BCN), 15 km southwest of city center"],"sources":["https://en.wikipedia.org/wiki/Barcelona","https://en.wikipedia.org/wiki/Barcelona–El_Prat_Airport"],"checked_at":"2026-11-03","status":"ok"}}],"offers":{"active":{"status":"missing","reason":"no_offers"},"active_with_related":{"status":"missing","reason":"no_offers"},"hospital_nights_median":{"status":"missing","reason":"no_offers"},"days_in_country_median":{"status":"missing","reason":"no_offers"},"top_offers":{"status":"missing","reason":"no_offers"},"packages":{"status":"missing","reason":"no_offers"},"related_packages":{"status":"missing","reason":"no_offers"},"other_packages":{"status":"missing","reason":"no_offers"}},"medical":{"indications":["Metastatic castration-resistant prostate cancer with PSMA-positive disease (Lu-PSMA)","Well-differentiated gastroenteropancreatic neuroendocrine tumours with somatostatin receptor expression (Lu-DOTATATE)","Progressive inoperable/metastatic disease after other therapies, imaging-confirmed uptake"],"contraindications":["Pregnancy (absolute)","Breastfeeding (must be stopped)","Lack of target uptake on PSMA or somatostatin receptor imaging","Severe bone marrow suppression","Severely impaired kidney function (relative or absolute depending on severity)","Severe liver dysfunction","Urinary obstruction or incontinence (relative)","Life expectancy too short to benefit"],"operation_hours":{"min":1,"max":5,"unit":"hours","qualifier":"Lu-PSMA visit takes about 1–3 hours; Lu-DOTATATE visit about 4–5 hours including amino acid infusion and observation."},"anesthesia":["none"],"sessions_or_stages":{"sessions":{"min":4,"max":6,"unit":"visits","qualifier":"Treatment cycles in a typical course; actual number depends on protocol, response and tolerance."},"stages":[{"code":"cycle_1","label":"First infusion cycle","after":{"min":0,"max":0,"unit":"days","qualifier":"Start of treatment."}},{"code":"subsequent_cycles","label":"Subsequent cycles repeated every 6 to 8 weeks","after":{"min":42,"max":56,"unit":"days","qualifier":"Second cycle timing from the first; later cycles follow at similar intervals."}}],"qualifier":"Typical protocols use 4 to 6 cycles at 6 to 8 week intervals, depending on the radioligand."},"hospital_nights":{"value":{"min":0,"max":1,"unit":"nights","qualifier":"Per cycle; usually same-day discharge; isolation stay may be needed under radiation rules."},"source":"parsed_details"},"treatment_conditions":["day_case"],"rehabilitation_days":{"min":2,"max":7,"unit":"days","qualifier":"Ordinary functional recovery after each cycle, mainly fatigue resolving."},"fly_home_after_days":{"min":1,"max":2,"unit":"days","qualifier":"Usually the day after infusion once radiation-release criteria are met; air travel may trigger detectors, so carry a treatment letter."},"back_to_work_days":{"min":1,"max":7,"unit":"days","qualifier":"Most resume office work within days; local radiation-safety rules limiting close contact may apply."},"exercise_resume_weeks":{"min":0,"max":1,"unit":"weeks","qualifier":"Light activity usually resumes within days as fatigue allows; depends on tolerance and radiation precautions."},"final_result_months":{"min":3,"max":6,"unit":"months","qualifier":"Typical time to assess response after a full course of cycles, with imaging and biomarkers; varies by disease."},"result_longevity":"The effect is disease control, not a cure. How long it lasts varies by disease, radioligand, disease burden and line of therapy.","main_risks":["Fatigue and nausea","Bone marrow suppression (anaemia, low platelets, low white cells)","Dry mouth (Lu-PSMA)","Kidney toxicity","Rare liver toxicity","Tumour flare or hormonal crisis (neuroendocrine tumours)","Rare long-term myelodysplastic syndrome or leukaemia","Radiation exposure to others, needing precautions"],"complication_rate_pct":{"min":10,"max":55,"unit":"percent","qualifier":"Grade 3-4 adverse events in pivotal trials, mainly blood count drops; mild fatigue and nausea are far more common."},"revision_rate_pct":{"status":"missing","reason":"not_collected"},"success":{"metric":"Progression-free survival at 20 months with Lu-177-DOTATATE versus high-dose octreotide (control 10.8%)","value":65.2,"horizon":"20 months","source":{"status":"missing","reason":"not_collected"},"evidence_status":"proven"},"scars":"There are no scars; the only mark is a small puncture site from the intravenous cannula.","pain":"Minimal procedural pain, only from IV cannulation; some patients have transient bone pain flare or nausea after infusion.","preparation":["Confirm target expression on PSMA or somatostatin receptor PET imaging","Baseline blood counts, kidney and liver function tests","Hydration on the day of treatment","Amino acid infusion for kidney protection (Lu-DOTATATE)","Anti-nausea medication before infusion","Review of current medications by the treating team"],"recovery_timeline":[{"phase":"Day of infusion","description":"IV infusion over about 30 minutes to 4 hours depending on protocol, with observation, then discharge.","restrictions":["Follow radiation safety precautions","Use a separate toilet where possible and flush twice"]},{"phase":"First week","description":"Possible fatigue, nausea and dry mouth; radiation precautions continue.","restrictions":["Limit close contact with others as instructed","Avoid contact with pregnant women and children as instructed"]},{"phase":"Weeks 2 to 6","description":"Blood count nadir and monitoring; fatigue gradually improves before the next cycle. Report fever, bleeding or severe fatigue.","restrictions":{"status":"missing","reason":"not_collected"}}],"follow_up_visits":[{"purpose":"assessment","requirement":"routine","after":{"min":14,"max":28,"unit":"days","qualifier":"Blood tests (blood counts, kidney and liver function) in the weeks after the first cycle."}},{"purpose":"result_review","requirement":"routine","after":{"min":84,"max":180,"unit":"days","qualifier":"Response imaging and biomarkers after the cycles are completed."}}],"sources":{"status":"missing","reason":"not_collected"},"clinic_checks":{"status":"ok","items":[{"id":"C1","text":"Check the qualifications of the medical team treating you","scope":"treatment_abroad","source":{"url":"https://www.nhs.uk/using-the-nhs/healthcare-abroad/going-abroad-for-treatment/treatment-abroad-checklist/","host":"nhs.uk","quote":"Have you checked the qualifications of the medical team treating you?","tier":"tier1_medical","fetched_at":"2026-11-12","http_status":200}},{"id":"C2","text":"Ask the treating doctor your questions about the treatment","scope":"treatment_abroad","source":{"url":"https://www.nhs.uk/using-the-nhs/healthcare-abroad/going-abroad-for-treatment/treatment-abroad-checklist/","host":"nhs.uk","quote":"Have you been able to ask them questions about your treatment?","tier":"tier1_medical","fetched_at":"2026-11-12","http_status":200}},{"id":"C3","text":"Ask whether a doctor is always present in the clinic and whether a high dependency or intensive care unit exists","scope":"treatment_abroad","source":{"url":"https://www.bapras.org.uk/public/patient-information/cosmetic-surgery/cosmetic-surgery-abroad","host":"bapras.org.uk","quote":"Is there always a doctor in the clinic and is there a high dependency or intensive care unit?","tier":"tier1_medical","fetched_at":"2026-11-11","http_status":200}},{"id":"C4","text":"Confirm the surgeon is trained and experienced in the exact procedure you are considering, not just in surgery generally","scope":"treatment_abroad","source":{"url":"https://www.isaps.org/discover/patients-home/considering-your-procedure-abroad/finding-a-surgeon-abroad/","host":"isaps.org","quote":"Verify that the surgeon is trained and experienced in performing the procedure you are considering.","tier":"tier1_medical","fetched_at":"2026-11-11","http_status":200}},{"id":"C5","text":"Expect two consultations with the treating surgeon before any surgery, which also gives you time to reconsider","scope":"treatment_abroad","source":{"url":"https://www.nhs.uk/conditions/cosmetic-procedures/cosmetic-surgery-abroad/","host":"nhs.uk","quote":"You should have 2 consultations with the surgeon treating you before any surgery.","tier":"tier1_medical","fetched_at":"2026-11-11","http_status":200}}],"checked_at":"2026-11-12","next_check_at":"2027-11-12","version":1},"red_flags":{"status":"ok","items":[{"id":"F1","text":"Only a helpline, not a named doctor, is offered for complications","scope":"treatment_abroad","source":{"url":"https://www.rcseng.ac.uk/patient-care/cosmetic-surgery/having-surgery-abroad","host":"rcseng.ac.uk","quote":"Make sure you have the contact details of a named doctor who can deal with any complications rather than a helpline.","tier":"tier1_medical","fetched_at":"2026-11-12","http_status":200}},{"id":"F2","text":"An advert or information that guarantees complete success should raise concerns","scope":"treatment_abroad","source":{"url":"https://travelaware.campaign.gov.uk/surgery-abroad-cut-out-the-risk/","host":"travelaware.campaign.gov.uk","quote":"Any advert or information that guarantees complete success should raise concerns.","tier":"tier1_medical","fetched_at":"2026-11-11","http_status":200}},{"id":"F3","text":"Forceful persuasion or cheap, time-limited offers pushing you into a quick decision","scope":"treatment_abroad","source":{"url":"https://travelaware.campaign.gov.uk/surgery-abroad-cut-out-the-risk/","host":"travelaware.campaign.gov.uk","quote":"Don’t be pressured into quick decisions either through forceful persuasion or cheap, time limited offers.","tier":"tier1_medical","fetched_at":"2026-11-11","http_status":200}}],"checked_at":"2026-11-12","next_check_at":"2027-11-12","version":1},"warning_signs":{"status":"ok","items":[{"id":"W1","text":"Vomiting blood or bleeding you cannot stop","urgency":"emergency","general":false,"source":{"url":"https://www.mskcc.org/cancer-care/patient-education/medications/adult/lutetium-lu-177-vipivotide-tetraxetan","host":"mskcc.org","quote":"Signs of bleeding like throwing up or coughing up blood; vomit that looks like coffee grounds; blood in the urine; black, red, or tarry stools; bleeding from the gums; abnormal vaginal bleeding; bruises without a cause or that get bigger; or bleeding you cannot stop.","tier":"tier1_medical","fetched_at":"2026-11-12","http_status":200}},{"id":"W2","text":"Unable to pass urine","urgency":"contact_clinic","general":false,"source":{"url":"https://www.mskcc.org/cancer-care/patient-education/medications/adult/lutetium-lu-177-vipivotide-tetraxetan","host":"mskcc.org","quote":"Signs of kidney problems like unable to pass urine, change in how much urine is passed, blood in the urine, or a big weight gain.","tier":"tier1_medical","fetched_at":"2026-11-12","http_status":200}},{"id":"W3","text":"Fever, chills, or sore throat","urgency":"contact_clinic","general":true,"source":{"url":"https://my.clevelandclinic.org/health/drugs/23722-lutetium-lu-177-vipivotide-tetraxetan-injection","host":"my.clevelandclinic.org","quote":"Call your care team for advice if you get a fever, chills, sore throat, or other symptoms of a cold or flu.","tier":"tier1_medical","fetched_at":"2026-11-12","http_status":200}}],"checked_at":"2026-11-12","next_check_at":"2027-11-12","version":1},"take_home":{"status":"ok","items":[{"id":"T1","text":"Tells home clinicians radiation may persist up to two months after therapy","document":"radioactive medicine card","source":{"url":"https://www.mskcc.org/cancer-care/patient-education/about-your-pluvicto-treatment","host":"mskcc.org","quote":"It says you can give off small amounts of radioactivity for up to 2 months after your treatment.","tier":"tier1_medical","fetched_at":"2026-11-12","http_status":200}},{"id":"T2","text":"Home doctor needs the clinic's follow-up recommendations in a written discharge summary","document":"discharge summary","source":{"url":"https://sbuhb.nhs.wales/about-us/individual-patient-commissioning/ipc-folder/advice-on-accessing-treatment-abroad","host":"sbuhb.nhs.wales","quote":"When you have treatment abroad, you must ask the treatment provider for their follow-up recommendations documented within a written discharge summary in English.","tier":"tier1_medical","fetched_at":"2026-11-11","http_status":200}}],"checked_at":"2026-11-12","next_check_at":"2027-11-12","version":1},"preop_tests":{"status":"ok","items":[{"id":"T1","name":"PET scan","aliases":["PET scan","PSMA PET","DOTATATE PET","somatostatin receptor PET imaging","PET imaging","PET/CT"],"kind":"imaging","origin":[{"field":"preparation","text":"Confirm target expression on PSMA or somatostatin receptor PET imaging"},{"field":"initial_assessment_documents","text":"PSMA or DOTATATE PET/CT report and images"}],"what_it_checks":{"text":"Shows where the tumor is and how well the ligand binds","source":{"url":"https://snmmi.org/MWM/Patients/Procedures/177Lu-PSMA-617-Therapy-Pluvicto.aspx","host":"snmmi.org","quote":"The PSMA ligand is similar to the one used for therapy but uses a different type of radioactive material that provides an image (PET/CT) to show where the tumor is and how well the ligand attaches to it.","tier":"tier1_medical","fetched_at":"2026-11-17","http_status":200}},"when_needed":{"status":"missing","reason":"no_official_source"},"test_prep":{"text":"Wait 45 to 60 minutes after the arm vein injection before the scan","source":{"url":"https://snmmi.org/MWM/Patients/Procedures/177Lu-PSMA-617-Therapy-Pluvicto.aspx","host":"snmmi.org","quote":"For this procedure, you will receive an injection into an arm vein and will wait 45-60 minutes to allow it to circulate before undergoing the scan.","tier":"tier1_medical","fetched_at":"2026-11-17","http_status":200}}},{"id":"T2","name":"Complete blood count","aliases":["Complete blood count","CBC","blood counts","full blood count"],"kind":"lab","origin":[{"field":"preparation","text":"Baseline blood counts, kidney and liver function tests"},{"field":"initial_assessment_documents","text":"Recent blood counts and kidney function tests"}],"what_it_checks":{"text":"Checks red cells, white cells and platelets, which therapy can lower","source":{"url":"https://snmmi.org/MWM/Patients/Procedures/177Lu-PSMA-617-Therapy-Pluvicto.aspx","host":"snmmi.org","quote":"The radiation may cause a decrease in your red cells, white cells, platelets, liver or kidney function.","tier":"tier1_medical","fetched_at":"2026-11-17","http_status":200}},"when_needed":{"type":"always","text":"Always","source":{"url":"https://snmmi.org/MWM/Patients/Procedures/177Lu-PSMA-617-Therapy-Pluvicto.aspx","host":"snmmi.org","quote":"Several days before each treatment, you will need to undergo blood to make sure it is safe to proceed.","tier":"tier1_medical","fetched_at":"2026-11-17","http_status":200}},"test_prep":null},{"id":"T3","name":"Kidney function test","aliases":["Kidney function test","kidney function tests","renal function test","renal function tests"],"kind":"lab","origin":[{"field":"preparation","text":"Baseline blood counts, kidney and liver function tests"},{"field":"initial_assessment_documents","text":"Recent blood counts and kidney function tests"}],"what_it_checks":{"text":"Checks kidney function, which the radiation can decrease","source":{"url":"https://snmmi.org/MWM/Patients/Procedures/177Lu-PSMA-617-Therapy-Pluvicto.aspx","host":"snmmi.org","quote":"The radiation may cause a decrease in your red cells, white cells, platelets, liver or kidney function.","tier":"tier1_medical","fetched_at":"2026-11-17","http_status":200}},"when_needed":{"type":"always","text":"Always","source":{"url":"https://snmmi.org/MWM/Patients/Procedures/177Lu-PSMA-617-Therapy-Pluvicto.aspx","host":"snmmi.org","quote":"Several days before each treatment, you will need to undergo blood to make sure it is safe to proceed.","tier":"tier1_medical","fetched_at":"2026-11-17","http_status":200}},"test_prep":null},{"id":"T4","name":"Liver function test","aliases":["Liver function test","liver function tests","LFT","LFTs"],"kind":"lab","origin":[{"field":"preparation","text":"Baseline blood counts, kidney and liver function tests"},{"field":"initial_assessment_documents","text":"Liver function tests"}],"what_it_checks":{"text":"Checks liver function, which the radiation can decrease","source":{"url":"https://snmmi.org/MWM/Patients/Procedures/177Lu-PSMA-617-Therapy-Pluvicto.aspx","host":"snmmi.org","quote":"The radiation may cause a decrease in your red cells, white cells, platelets, liver or kidney function.","tier":"tier1_medical","fetched_at":"2026-11-17","http_status":200}},"when_needed":{"type":"always","text":"Always","source":{"url":"https://snmmi.org/MWM/Patients/Procedures/177Lu-PSMA-617-Therapy-Pluvicto.aspx","host":"snmmi.org","quote":"Several days before each treatment, you will need to undergo blood to make sure it is safe to proceed.","tier":"tier1_medical","fetched_at":"2026-11-17","http_status":200}},"test_prep":null},{"id":"T5","name":"CT scan","aliases":["CT scan","CT","computed tomography"],"kind":"imaging","origin":[{"field":"initial_assessment_documents","text":"Recent CT or MRI reports (if available)"}],"what_it_checks":{"status":"missing","reason":"no_official_source"},"when_needed":{"status":"missing","reason":"no_official_source"},"test_prep":null},{"id":"T6","name":"MRI scan","aliases":["MRI scan","MRI","magnetic resonance imaging"],"kind":"imaging","origin":[{"field":"initial_assessment_documents","text":"Recent CT or MRI reports (if available)"}],"what_it_checks":{"status":"missing","reason":"no_official_source"},"when_needed":{"status":"missing","reason":"no_official_source"},"test_prep":null},{"id":"T7","name":"Blood tests","aliases":["Blood tests"],"kind":"lab","origin":[{"field":"packages","text":"Blood tests"}],"what_it_checks":{"text":"Checks red cells, white cells, platelets, liver and kidney function","source":{"url":"https://snmmi.org/MWM/Patients/Procedures/177Lu-PSMA-617-Therapy-Pluvicto.aspx","host":"snmmi.org","quote":"These include tests for your red cells, white cells, platelets, liver and kidney function.","tier":"tier1_medical","fetched_at":"2026-11-17","http_status":200}},"when_needed":{"type":"always","text":"Always","source":{"url":"https://snmmi.org/MWM/Patients/Procedures/177Lu-PSMA-617-Therapy-Pluvicto.aspx","host":"snmmi.org","quote":"Several days before each treatment, you will need to undergo blood to make sure it is safe to proceed.","tier":"tier1_medical","fetched_at":"2026-11-17","http_status":200}},"test_prep":{"text":"Have blood testing several days before each treatment","source":{"url":"https://snmmi.org/MWM/Patients/Procedures/177Lu-PSMA-617-Therapy-Pluvicto.aspx","host":"snmmi.org","quote":"Several days before each treatment, you will need to undergo blood to make sure it is safe to proceed.","tier":"tier1_medical","fetched_at":"2026-11-17","http_status":200}}}],"checked_at":"2026-11-17","next_check_at":"2027-11-17","version":1},"prep_in_advance":{"status":"missing","reason":"no_official_source","checked_at":"2026-11-17","next_check_at":"2027-02-15"},"visit_and_day":{"status":"missing","reason":"no_official_source","checked_at":"2026-11-17","next_check_at":"2027-02-15"},"if_something_changes":{"status":"ok","items":[{"id":"S1","text":"Pregnancy or breastfeeding should be reported because Lu-177 treatment should not be given","source":{"url":"https://www.uclh.nhs.uk/patients-and-visitors/patient-information-pages/information-adults-having-lutetium-lu-177-treatment","host":"uclh.nhs.uk","quote":"You should not have Lu-177 treatment if you are pregnant or breastfeeding.","tier":"tier1_medical","fetched_at":"2026-11-17","http_status":200}}],"checked_at":"2026-11-17","next_check_at":"2027-11-17","version":1}},"parsed_details":{"procedure_type":"therapy","fields":{"anesthesia":["none"],"back_to_work_days":{"min":1,"max":7,"unit":"days","qualifier":"Most resume office work within days; local radiation-safety rules limiting close contact may apply."},"complication_rate_pct":{"min":10,"max":55,"unit":"percent","qualifier":"Grade 3-4 adverse events in pivotal trials, mainly blood count drops; mild fatigue and nausea are far more common."},"contraindications":["Pregnancy (absolute)","Breastfeeding (must be stopped)","Lack of target uptake on PSMA or somatostatin receptor imaging","Severe bone marrow suppression","Severely impaired kidney function (relative or absolute depending on severity)","Severe liver dysfunction","Urinary obstruction or incontinence (relative)","Life expectancy too short to benefit"],"days_in_clinic":{"min":0,"max":1,"unit":"nights","qualifier":"Per cycle; usually same-day discharge; isolation stay may be needed under radiation rules."},"diagnostic_duration_minutes":null,"diagnostic_preparation":null,"diagnostic_referral_needed":null,"diagnostic_result_time_hours":null,"exercise_resume_weeks":{"min":0,"max":1,"unit":"weeks","qualifier":"Light activity usually resumes within days as fatigue allows; depends on tolerance and radiation precautions."},"final_result_months":{"min":3,"max":6,"unit":"months","qualifier":"Typical time to assess response after a full course of cycles, with imaging and biomarkers; varies by disease."},"fly_home_after_days":{"min":1,"max":2,"unit":"days","qualifier":"Usually the day after infusion once radiation-release criteria are met; air travel may trigger detectors, so carry a treatment letter."},"follow_up_visits":[{"purpose":"assessment","requirement":"routine","after":{"min":14,"max":28,"unit":"days","qualifier":"Blood tests (blood counts, kidney and liver function) in the weeks after the first cycle."}},{"purpose":"result_review","requirement":"routine","after":{"min":84,"max":180,"unit":"days","qualifier":"Response imaging and biomarkers after the cycles are completed."}}],"indications":["Metastatic castration-resistant prostate cancer with PSMA-positive disease (Lu-PSMA)","Well-differentiated gastroenteropancreatic neuroendocrine tumours with somatostatin receptor expression (Lu-DOTATATE)","Progressive inoperable/metastatic disease after other therapies, imaging-confirmed uptake"],"main_risks":["Fatigue and nausea","Bone marrow suppression (anaemia, low platelets, low white cells)","Dry mouth (Lu-PSMA)","Kidney toxicity","Rare liver toxicity","Tumour flare or hormonal crisis (neuroendocrine tumours)","Rare long-term myelodysplastic syndrome or leukaemia","Radiation exposure to others, needing precautions"],"pain":"Minimal procedural pain, only from IV cannulation; some patients have transient bone pain flare or nausea after infusion.","preparation":["Confirm target expression on PSMA or somatostatin receptor PET imaging","Baseline blood counts, kidney and liver function tests","Hydration on the day of treatment","Amino acid infusion for kidney protection (Lu-DOTATATE)","Anti-nausea medication before infusion","Review of current medications by the treating team"],"recovery_timeline":[{"phase":"Day of infusion","description":"IV infusion over about 30 minutes to 4 hours depending on protocol, with observation, then discharge.","restrictions":["Follow radiation safety precautions","Use a separate toilet where possible and flush twice"]},{"phase":"First week","description":"Possible fatigue, nausea and dry mouth; radiation precautions continue.","restrictions":["Limit close contact with others as instructed","Avoid contact with pregnant women and children as instructed"]},{"phase":"Weeks 2 to 6","description":"Blood count nadir and monitoring; fatigue gradually improves before the next cycle. Report fever, bleeding or severe fatigue.","restrictions":[]}],"rehabilitation_days":{"min":2,"max":7,"unit":"days","qualifier":"Ordinary functional recovery after each cycle, mainly fatigue resolving."},"result_longevity":"The effect is disease control, not a cure. How long it lasts varies by disease, radioligand, disease burden and line of therapy.","revision_rate_pct":null,"scars":"There are no scars; the only mark is a small puncture site from the intravenous cannula.","sessions_or_stages":{"sessions":{"min":4,"max":6,"unit":"visits","qualifier":"Treatment cycles in a typical course; actual number depends on protocol, response and tolerance."},"stages":[{"code":"cycle_1","label":"First infusion cycle","after":{"min":0,"max":0,"unit":"days","qualifier":"Start of treatment."}},{"code":"subsequent_cycles","label":"Subsequent cycles repeated every 6 to 8 weeks","after":{"min":42,"max":56,"unit":"days","qualifier":"Second cycle timing from the first; later cycles follow at similar intervals."}}],"qualifier":"Typical protocols use 4 to 6 cycles at 6 to 8 week intervals, depending on the radioligand."},"success":{"metric":"Progression-free survival at 20 months with Lu-177-DOTATATE versus high-dose octreotide (control 10.8%)","value":65.2,"unit":"percent","horizon":"20 months","evidence_status":"proven","population":"Adults with progressive, inoperable, somatostatin-receptor-positive midgut neuroendocrine tumours"},"techniques":[{"name":"Lu-177 PSMA-617 (Lu-PSMA) radioligand therapy","suits_whom":"Adults with PSMA-positive metastatic castration-resistant prostate cancer after prior therapy.","recovery":"Outpatient infusion; fatigue and dry mouth are common for days to weeks."},{"name":"Lu-177 DOTATATE peptide receptor radionuclide therapy","suits_whom":"Adults with somatostatin receptor-positive neuroendocrine tumours.","recovery":"Same-day or short stay; amino acid co-infusion; fatigue and nausea settle in days."}],"treatment_conditions":["day_case"],"treatment_duration_hours":{"min":1,"max":5,"unit":"hours","qualifier":"Lu-PSMA visit takes about 1–3 hours; Lu-DOTATATE visit about 4–5 hours including amino acid infusion and observation."},"initial_assessment_documents":["PSMA or DOTATATE PET/CT report and images","Biopsy histopathology report","Recent blood counts and kidney function tests","Liver function tests","Summary of prior cancer treatments","Recent CT or MRI reports (if available)"],"travel_trips":{"min":4,"max":6,"one_trip_possible":false,"qualifier":"One trip per cycle, given 6-8 weeks apart; stay 1-2 days, longer if isolation is required."},"clinic_checks":{"status":"ok","items":[{"id":"C1","text":"Check the qualifications of the medical team treating you","scope":"treatment_abroad","source":{"url":"https://www.nhs.uk/using-the-nhs/healthcare-abroad/going-abroad-for-treatment/treatment-abroad-checklist/","host":"nhs.uk","quote":"Have you checked the qualifications of the medical team treating you?","tier":"tier1_medical","fetched_at":"2026-11-12","http_status":200}},{"id":"C2","text":"Ask the treating doctor your questions about the treatment","scope":"treatment_abroad","source":{"url":"https://www.nhs.uk/using-the-nhs/healthcare-abroad/going-abroad-for-treatment/treatment-abroad-checklist/","host":"nhs.uk","quote":"Have you been able to ask them questions about your treatment?","tier":"tier1_medical","fetched_at":"2026-11-12","http_status":200}},{"id":"C3","text":"Ask whether a doctor is always present in the clinic and whether a high dependency or intensive care unit exists","scope":"treatment_abroad","source":{"url":"https://www.bapras.org.uk/public/patient-information/cosmetic-surgery/cosmetic-surgery-abroad","host":"bapras.org.uk","quote":"Is there always a doctor in the clinic and is there a high dependency or intensive care unit?","tier":"tier1_medical","fetched_at":"2026-11-11","http_status":200}},{"id":"C4","text":"Confirm the surgeon is trained and experienced in the exact procedure you are considering, not just in surgery generally","scope":"treatment_abroad","source":{"url":"https://www.isaps.org/discover/patients-home/considering-your-procedure-abroad/finding-a-surgeon-abroad/","host":"isaps.org","quote":"Verify that the surgeon is trained and experienced in performing the procedure you are considering.","tier":"tier1_medical","fetched_at":"2026-11-11","http_status":200}},{"id":"C5","text":"Expect two consultations with the treating surgeon before any surgery, which also gives you time to reconsider","scope":"treatment_abroad","source":{"url":"https://www.nhs.uk/conditions/cosmetic-procedures/cosmetic-surgery-abroad/","host":"nhs.uk","quote":"You should have 2 consultations with the surgeon treating you before any surgery.","tier":"tier1_medical","fetched_at":"2026-11-11","http_status":200}}],"checked_at":"2026-11-12","next_check_at":"2027-11-12","version":1},"red_flags":{"status":"ok","items":[{"id":"F1","text":"Only a helpline, not a named doctor, is offered for complications","scope":"treatment_abroad","source":{"url":"https://www.rcseng.ac.uk/patient-care/cosmetic-surgery/having-surgery-abroad","host":"rcseng.ac.uk","quote":"Make sure you have the contact details of a named doctor who can deal with any complications rather than a helpline.","tier":"tier1_medical","fetched_at":"2026-11-12","http_status":200}},{"id":"F2","text":"An advert or information that guarantees complete success should raise concerns","scope":"treatment_abroad","source":{"url":"https://travelaware.campaign.gov.uk/surgery-abroad-cut-out-the-risk/","host":"travelaware.campaign.gov.uk","quote":"Any advert or information that guarantees complete success should raise concerns.","tier":"tier1_medical","fetched_at":"2026-11-11","http_status":200}},{"id":"F3","text":"Forceful persuasion or cheap, time-limited offers pushing you into a quick decision","scope":"treatment_abroad","source":{"url":"https://travelaware.campaign.gov.uk/surgery-abroad-cut-out-the-risk/","host":"travelaware.campaign.gov.uk","quote":"Don’t be pressured into quick decisions either through forceful persuasion or cheap, time limited offers.","tier":"tier1_medical","fetched_at":"2026-11-11","http_status":200}}],"checked_at":"2026-11-12","next_check_at":"2027-11-12","version":1},"warning_signs":{"status":"ok","items":[{"id":"W1","text":"Vomiting blood or bleeding you cannot stop","urgency":"emergency","general":false,"source":{"url":"https://www.mskcc.org/cancer-care/patient-education/medications/adult/lutetium-lu-177-vipivotide-tetraxetan","host":"mskcc.org","quote":"Signs of bleeding like throwing up or coughing up blood; vomit that looks like coffee grounds; blood in the urine; black, red, or tarry stools; bleeding from the gums; abnormal vaginal bleeding; bruises without a cause or that get bigger; or bleeding you cannot stop.","tier":"tier1_medical","fetched_at":"2026-11-12","http_status":200}},{"id":"W2","text":"Unable to pass urine","urgency":"contact_clinic","general":false,"source":{"url":"https://www.mskcc.org/cancer-care/patient-education/medications/adult/lutetium-lu-177-vipivotide-tetraxetan","host":"mskcc.org","quote":"Signs of kidney problems like unable to pass urine, change in how much urine is passed, blood in the urine, or a big weight gain.","tier":"tier1_medical","fetched_at":"2026-11-12","http_status":200}},{"id":"W3","text":"Fever, chills, or sore throat","urgency":"contact_clinic","general":true,"source":{"url":"https://my.clevelandclinic.org/health/drugs/23722-lutetium-lu-177-vipivotide-tetraxetan-injection","host":"my.clevelandclinic.org","quote":"Call your care team for advice if you get a fever, chills, sore throat, or other symptoms of a cold or flu.","tier":"tier1_medical","fetched_at":"2026-11-12","http_status":200}}],"checked_at":"2026-11-12","next_check_at":"2027-11-12","version":1},"take_home":{"status":"ok","items":[{"id":"T1","text":"Tells home clinicians radiation may persist up to two months after therapy","document":"radioactive medicine card","source":{"url":"https://www.mskcc.org/cancer-care/patient-education/about-your-pluvicto-treatment","host":"mskcc.org","quote":"It says you can give off small amounts of radioactivity for up to 2 months after your treatment.","tier":"tier1_medical","fetched_at":"2026-11-12","http_status":200}},{"id":"T2","text":"Home doctor needs the clinic's follow-up recommendations in a written discharge summary","document":"discharge summary","source":{"url":"https://sbuhb.nhs.wales/about-us/individual-patient-commissioning/ipc-folder/advice-on-accessing-treatment-abroad","host":"sbuhb.nhs.wales","quote":"When you have treatment abroad, you must ask the treatment provider for their follow-up recommendations documented within a written discharge summary in English.","tier":"tier1_medical","fetched_at":"2026-11-11","http_status":200}}],"checked_at":"2026-11-12","next_check_at":"2027-11-12","version":1},"alternatives":{"status":"ok","items":[{"id":"A1","text":"Surgery is not an option for your neuroendocrine tumor","name":"Hormone therapy medications","source":{"url":"https://my.clevelandclinic.org/health/treatments/24073-peptide-receptor-radionuclide-therapy-prrt","host":"my.clevelandclinic.org","quote":"If surgery isn’t an option, people with NETs may receive hormone therapy medications.","tier":"tier1_medical","fetched_at":"2026-11-12","http_status":200},"operation_id":null}],"checked_at":"2026-11-12","next_check_at":"2027-11-12","version":1},"technique_details":{"status":"ok","items":[{"id":"lu-177-psma-617-radioligand","name":"Lu-177 PSMA-617 (Lu-PSMA) radioligand therapy","how_it_works":{"text":"A radioactive drug targets cancer cells and delivers radiation directly to them","source":{"url":"https://medlineplus.gov/druginfo/meds/a622063.html","host":"medlineplus.gov","quote":"It works by targeting and delivering radiation directly to cancer cells which damages and kills these cells.","tier":"tier1_medical","fetched_at":"2026-11-17","http_status":200}},"recovery_daily":{"status":"missing","reason":"no_official_source"}},{"id":"lu-177-dotatate-peptide","name":"Lu-177 DOTATATE peptide receptor radionuclide therapy","how_it_works":{"text":"A radioactive drug enters tumor cells that carry somatostatin receptors","source":{"url":"https://www.cancer.gov/news-events/cancer-currents-blog/2018/lutathera-fda-gastrointestinal-nets","host":"cancer.gov","quote":"The drug then enters these somatostatin receptor−positive tumor cells,","tier":"tier1_medical","fetched_at":"2026-11-12","http_status":200}},"recovery_daily":{"status":"missing","reason":"no_official_source"}}],"checked_at":"2026-11-12","next_check_at":"2027-11-12","version":1},"preop_tests":{"status":"ok","items":[{"id":"T1","name":"PET scan","aliases":["PET scan","PSMA PET","DOTATATE PET","somatostatin receptor PET imaging","PET imaging","PET/CT"],"kind":"imaging","origin":[{"field":"preparation","text":"Confirm target expression on PSMA or somatostatin receptor PET imaging"},{"field":"initial_assessment_documents","text":"PSMA or DOTATATE PET/CT report and images"}],"what_it_checks":{"text":"Shows where the tumor is and how well the ligand binds","source":{"url":"https://snmmi.org/MWM/Patients/Procedures/177Lu-PSMA-617-Therapy-Pluvicto.aspx","host":"snmmi.org","quote":"The PSMA ligand is similar to the one used for therapy but uses a different type of radioactive material that provides an image (PET/CT) to show where the tumor is and how well the ligand attaches to it.","tier":"tier1_medical","fetched_at":"2026-11-17","http_status":200}},"when_needed":{"status":"missing","reason":"no_official_source"},"test_prep":{"text":"Wait 45 to 60 minutes after the arm vein injection before the scan","source":{"url":"https://snmmi.org/MWM/Patients/Procedures/177Lu-PSMA-617-Therapy-Pluvicto.aspx","host":"snmmi.org","quote":"For this procedure, you will receive an injection into an arm vein and will wait 45-60 minutes to allow it to circulate before undergoing the scan.","tier":"tier1_medical","fetched_at":"2026-11-17","http_status":200}}},{"id":"T2","name":"Complete blood count","aliases":["Complete blood count","CBC","blood counts","full blood count"],"kind":"lab","origin":[{"field":"preparation","text":"Baseline blood counts, kidney and liver function tests"},{"field":"initial_assessment_documents","text":"Recent blood counts and kidney function tests"}],"what_it_checks":{"text":"Checks red cells, white cells and platelets, which therapy can lower","source":{"url":"https://snmmi.org/MWM/Patients/Procedures/177Lu-PSMA-617-Therapy-Pluvicto.aspx","host":"snmmi.org","quote":"The radiation may cause a decrease in your red cells, white cells, platelets, liver or kidney function.","tier":"tier1_medical","fetched_at":"2026-11-17","http_status":200}},"when_needed":{"type":"always","text":"Always","source":{"url":"https://snmmi.org/MWM/Patients/Procedures/177Lu-PSMA-617-Therapy-Pluvicto.aspx","host":"snmmi.org","quote":"Several days before each treatment, you will need to undergo blood to make sure it is safe to proceed.","tier":"tier1_medical","fetched_at":"2026-11-17","http_status":200}},"test_prep":null},{"id":"T3","name":"Kidney function test","aliases":["Kidney function test","kidney function tests","renal function test","renal function tests"],"kind":"lab","origin":[{"field":"preparation","text":"Baseline blood counts, kidney and liver function tests"},{"field":"initial_assessment_documents","text":"Recent blood counts and kidney function tests"}],"what_it_checks":{"text":"Checks kidney function, which the radiation can decrease","source":{"url":"https://snmmi.org/MWM/Patients/Procedures/177Lu-PSMA-617-Therapy-Pluvicto.aspx","host":"snmmi.org","quote":"The radiation may cause a decrease in your red cells, white cells, platelets, liver or kidney function.","tier":"tier1_medical","fetched_at":"2026-11-17","http_status":200}},"when_needed":{"type":"always","text":"Always","source":{"url":"https://snmmi.org/MWM/Patients/Procedures/177Lu-PSMA-617-Therapy-Pluvicto.aspx","host":"snmmi.org","quote":"Several days before each treatment, you will need to undergo blood to make sure it is safe to proceed.","tier":"tier1_medical","fetched_at":"2026-11-17","http_status":200}},"test_prep":null},{"id":"T4","name":"Liver function test","aliases":["Liver function test","liver function tests","LFT","LFTs"],"kind":"lab","origin":[{"field":"preparation","text":"Baseline blood counts, kidney and liver function tests"},{"field":"initial_assessment_documents","text":"Liver function tests"}],"what_it_checks":{"text":"Checks liver function, which the radiation can decrease","source":{"url":"https://snmmi.org/MWM/Patients/Procedures/177Lu-PSMA-617-Therapy-Pluvicto.aspx","host":"snmmi.org","quote":"The radiation may cause a decrease in your red cells, white cells, platelets, liver or kidney function.","tier":"tier1_medical","fetched_at":"2026-11-17","http_status":200}},"when_needed":{"type":"always","text":"Always","source":{"url":"https://snmmi.org/MWM/Patients/Procedures/177Lu-PSMA-617-Therapy-Pluvicto.aspx","host":"snmmi.org","quote":"Several days before each treatment, you will need to undergo blood to make sure it is safe to proceed.","tier":"tier1_medical","fetched_at":"2026-11-17","http_status":200}},"test_prep":null},{"id":"T5","name":"CT scan","aliases":["CT scan","CT","computed tomography"],"kind":"imaging","origin":[{"field":"initial_assessment_documents","text":"Recent CT or MRI reports (if available)"}],"what_it_checks":{"status":"missing","reason":"no_official_source"},"when_needed":{"status":"missing","reason":"no_official_source"},"test_prep":null},{"id":"T6","name":"MRI scan","aliases":["MRI scan","MRI","magnetic resonance imaging"],"kind":"imaging","origin":[{"field":"initial_assessment_documents","text":"Recent CT or MRI reports (if available)"}],"what_it_checks":{"status":"missing","reason":"no_official_source"},"when_needed":{"status":"missing","reason":"no_official_source"},"test_prep":null},{"id":"T7","name":"Blood tests","aliases":["Blood tests"],"kind":"lab","origin":[{"field":"packages","text":"Blood tests"}],"what_it_checks":{"text":"Checks red cells, white cells, platelets, liver and kidney function","source":{"url":"https://snmmi.org/MWM/Patients/Procedures/177Lu-PSMA-617-Therapy-Pluvicto.aspx","host":"snmmi.org","quote":"These include tests for your red cells, white cells, platelets, liver and kidney function.","tier":"tier1_medical","fetched_at":"2026-11-17","http_status":200}},"when_needed":{"type":"always","text":"Always","source":{"url":"https://snmmi.org/MWM/Patients/Procedures/177Lu-PSMA-617-Therapy-Pluvicto.aspx","host":"snmmi.org","quote":"Several days before each treatment, you will need to undergo blood to make sure it is safe to proceed.","tier":"tier1_medical","fetched_at":"2026-11-17","http_status":200}},"test_prep":{"text":"Have blood testing several days before each treatment","source":{"url":"https://snmmi.org/MWM/Patients/Procedures/177Lu-PSMA-617-Therapy-Pluvicto.aspx","host":"snmmi.org","quote":"Several days before each treatment, you will need to undergo blood to make sure it is safe to proceed.","tier":"tier1_medical","fetched_at":"2026-11-17","http_status":200}}}],"checked_at":"2026-11-17","next_check_at":"2027-11-17","version":1},"prep_in_advance":{"status":"missing","reason":"no_official_source","checked_at":"2026-11-17","next_check_at":"2027-02-15"},"visit_and_day":{"status":"missing","reason":"no_official_source","checked_at":"2026-11-17","next_check_at":"2027-02-15"},"if_something_changes":{"status":"ok","items":[{"id":"S1","text":"Pregnancy or breastfeeding should be reported because Lu-177 treatment should not be given","source":{"url":"https://www.uclh.nhs.uk/patients-and-visitors/patient-information-pages/information-adults-having-lutetium-lu-177-treatment","host":"uclh.nhs.uk","quote":"You should not have Lu-177 treatment if you are pregnant or breastfeeding.","tier":"tier1_medical","fetched_at":"2026-11-17","http_status":200}}],"checked_at":"2026-11-17","next_check_at":"2027-11-17","version":1}}},"techniques":[{"id":"lu-177-psma-617-radioligand","name":"Lu-177 PSMA-617 (Lu-PSMA) radioligand therapy","how_it_works":{"id":"H1","text":"A radioactive drug targets cancer cells and delivers radiation directly to them","source":{"url":"https://medlineplus.gov/druginfo/meds/a622063.html","host":"medlineplus.gov","quote":"It works by targeting and delivering radiation directly to cancer cells which damages and kills these cells.","tier":"tier1_medical","fetched_at":"2026-11-17","http_status":200}},"recovery_daily":{"status":"missing","reason":"no_official_source"},"suits_whom":"Adults with PSMA-positive metastatic castration-resistant prostate cancer after prior therapy.","price_from":7500,"recovery":"Outpatient infusion; fatigue and dry mouth are common for days to weeks."},{"id":"lu-177-dotatate-peptide","name":"Lu-177 DOTATATE peptide receptor radionuclide therapy","how_it_works":{"id":"H1","text":"A radioactive drug enters tumor cells that carry somatostatin receptors","source":{"url":"https://www.cancer.gov/news-events/cancer-currents-blog/2018/lutathera-fda-gastrointestinal-nets","host":"cancer.gov","quote":"The drug then enters these somatostatin receptor−positive tumor cells,","tier":"tier1_medical","fetched_at":"2026-11-12","http_status":200}},"recovery_daily":{"status":"missing","reason":"no_official_source"},"suits_whom":"Adults with somatostatin receptor-positive neuroendocrine tumours.","price_from":8500,"recovery":"Same-day or short stay; amino acid co-infusion; fatigue and nausea settle in days."}],"alternatives":{"status":"ok","items":[{"id":"A1","text":"Surgery is not an option for your neuroendocrine tumor","name":"Hormone therapy medications","source":{"url":"https://my.clevelandclinic.org/health/treatments/24073-peptide-receptor-radionuclide-therapy-prrt","host":"my.clevelandclinic.org","quote":"If surgery isn’t an option, people with NETs may receive hormone therapy medications.","tier":"tier1_medical","fetched_at":"2026-11-12","http_status":200},"operation_id":null}],"checked_at":"2026-11-12","next_check_at":"2027-11-12","version":1},"diagnostic":{"status":"not_applicable"},"country":{"why":{"status":"missing","reason":"no_official_source","checked_at":"2026-11-11","next_check_at":"2027-02-09"},"travel":{"status":"ok","items":[{"id":"V1","item":"passport_validity","audience":"uk","volatile":true,"text":"The passport must have an expiry date at least 3 months after you plan to leave the Schengen area","source":{"url":"https://www.gov.uk/foreign-travel-advice/spain/entry-requirements","host":"gov.uk","quote":"have an ‘expiry date’ at least 3 months after the day you plan to leave the Schengen area (the expiry date does not need to be within 10 years of the date of issue)","tier":"official_travel","fetched_at":"2026-11-11","http_status":200}},{"id":"V2","item":"medicines","audience":"all","volatile":false,"text":"Carry prescription medication in its original packaging, along with your doctor's prescription","source":{"url":"https://travel.state.gov/content/travel/en/international-travel/International-Travel-Country-Information-Pages/Spain.html","host":"travel.state.gov","quote":"Always carry your prescription medication in original packaging, along with your doctor’s prescription.","tier":"official_travel","fetched_at":"2026-11-11","http_status":403}},{"id":"V3","item":"prescriptions","audience":"us","volatile":false,"text":"Medications that require a prescription in the United States also require a local doctor's prescription in Spain","source":{"url":"https://travel.state.gov/content/travel/en/international-travel/International-Travel-Country-Information-Pages/Spain.html","host":"travel.state.gov","quote":"Medications requiring prescriptions in the United States also require a local doctor’s prescription in Spain.","tier":"official_travel","fetched_at":"2026-11-11","http_status":403}},{"id":"V4","item":"ghic","audience":"uk","volatile":false,"text":"A GHIC or EHIC is needed to get medically necessary state healthcare in Spain","source":{"url":"https://www.gov.uk/foreign-travel-advice/spain/health","host":"gov.uk","quote":"To get medically necessary state healthcare in Spain, you need a Global Health Insurance Card ( GHIC ) or a European Health Insurance Card ( EHIC ).","tier":"official_travel","fetched_at":"2026-11-11","http_status":200}},{"id":"V5","item":"hospital_payment","audience":"all","volatile":false,"text":"Private hospitals usually require payment or proof of insurance or funds before admitting a patient","source":{"url":"https://travel.state.gov/content/travel/en/international-travel/International-Travel-Country-Information-Pages/Spain.html","host":"travel.state.gov","quote":"Private hospitals usually require payment or proof insurance or funds before admitting a patient.","tier":"official_travel","fetched_at":"2026-11-11","http_status":403}},{"id":"V6","item":"emergency_number","audience":"all","volatile":false,"text":"Dial 112 and ask for an ambulance","source":{"url":"https://www.gov.uk/foreign-travel-advice/spain/health","host":"gov.uk","quote":"Dial 112 and ask for an ambulance.","tier":"official_travel","fetched_at":"2026-11-11","http_status":200}}],"checked_at":"2026-11-11","next_check_at":"2026-12-11","version":1},"other_countries_with_page":["austria","china","germany","india","israel","turkey"]},"often_combined_with":{"status":"missing","reason":"not_collected"},"reviews":{"avg_rating":4.7,"count":515,"scope":"clinic","rating_scale":5,"pros":{"status":"missing","reason":"not_collected"},"cons":{"status":"missing","reason":"not_collected"}},"current":{"seo_text":"<p>Lutetium-177 therapy in Spain typically costs from _op_830_price_from_ to _op_830_price_to_. The total price depends on the clinic tier and the number of treatment cycles. In the US, similar procedures cost around _price_compare_US_average_ on average. Patients save around _price_percent_discount_% compared to US prices. Inclusions generally comprise the radiopharmaceutical, medical consultations, blood work, and inpatient monitoring.</p>\n\n<ul>\n<li><strong>Number of cycles:</strong> A full course often requires three to four sessions to be effective.</li>\n<li><strong>Resource hubs:</strong> Most specialized nuclear medicine treatments are concentrated in Madrid and Barcelona.</li>\n<li><strong>Tracer type:</strong> Costs may vary based on using PSMA-617 or DOTATATE specific radiopharmaceuticals.</li>\n<li><strong>Location premium:</strong> Specialized centers in Barcelona may charge 15-20% more than regional oncology facilities.</li>\n</ul>\n\n<p><strong>Bookimed Expert Insight:</strong> Spain offers a high-value balance between ultra-modern infrastructure and cost. For example, Centro Médico Teknon is an official medical service for major events. It holds Joint Commission International (JCI) accreditation and treats high-profile international figures. While University Hospital HM Madrid handles over 2.3 million outpatients annually, demonstrating massive clinical experience. Choosing these established hubs ensures access to the latest nuclear medicine protocols at European standards. Pricing remains significantly lower than in Germany or the United Kingdom.</p>","faq":[{"q":"What is Lutetium-177 therapy and what is it used for in Spain?","a":"<p>Lutetium-177 therapy in Spain is a targeted radionuclide treatment using precision medicine to destroy advanced cancer cells. This radioligand radiation therapy utilizes its radioactive isotope to target specific biomarkers like PSMA, effectively treating metastatic prostate cancer and neuroendocrine tumors while preserving surrounding healthy tissue.</p> <ul> <li><strong>Targeted conditions:</strong> Primarily treats somatostatin receptor-positive neuroendocrine tumors and hormone-resistant metastatic prostate cancer.</li> <li><strong>Treatment mechanism:</strong> Uses Pluvicto (Lu-177 PSMA) molecules to deliver radiation directly to tumors.</li> <li><strong>Clinical effectiveness:</strong> Shown to reduce tumor size and lower PSA levels in advanced cases.</li> <li><strong>Recovery timeline:</strong> Common side effects like fatigue or dry mouth typically resolve within 7 days.</li> </ul> <p><strong>Bookimed Expert Insight:</strong> Spain has become a major European hub for this therapy due to Joint Commission International (JCI) accredited centers like Centro Médico Teknon in Barcelona. While clinical trials like VISION prove its efficiency, patients often choose Madrid or Barcelona clinics because they offer advanced 177-Lu PSMA alongside specialist oncology teams. This concentration of expertise allows for highly coordinated multidisciplinary care that is often unavailable in smaller regional centers.</p> <p><strong>Patient Consensus:</strong> Patients describe the side effects as manageable compared to traditional chemotherapy, though most emphasize the importance of verifying drug availability directly with hospitals before traveling. The emotional relief often stems from having an effective treatment option for stage 4 cancer when other therapies have failed.</p>"},{"q":"Is Lutetium-177 therapy covered by the public health system (SNS) in Spain?","a":"<p>Spain's public health system (SNS) covers Lutetium-177 therapy as of 2026, primarily through the approved radiopharmaceuticals Pluvicto and Lutathera. Funding is restricted to hospital use for specific indications, including metastatic castration-resistant prostate cancer and neuroendocrine tumors expressing somatostatin receptors.</p> <ul> <li><strong>Approved indicators:</strong> Coverage applies to advanced mCRPC patients expressing the PSMA protein.</li> <li><strong>Restricted use:</strong> Drugs are classified as hospital-only under the BIFIMED financing tool.</li> <li><strong>Regional access:</strong> Authorization depends on local regional health authorities in different autonomous communities.</li> <li><strong>Facility requirements:</strong> Treatment occurs in nuclear medicine departments within major university hospitals.</li> </ul> <p><strong>Bookimed Expert Insight:</strong> Spain ranks third globally in our medical network for oncology specialized care. Centers like Centro Médico Teknon in Barcelona hold JCI accreditation, which is the gold standard. While public coverage exists, many patients choose private JCI-certified hubs to avoid regional authorization delays. These facilities handle over 10,000 patients annually and offer advanced molecular imaging.</p> <p><strong>Patient Consensus:</strong> Patients emphasize consulting specialized oncology departments like GenesisCare to verify eligibility criteria early. Many report that navigating regional health authority approvals is a critical first step in accessing treatment.</p>"},{"q":"What are the side effects of Lutetium-177 therapy?","a":"<p>Lutetium-177 therapy side effects typically include temporary fatigue, nausea, and dry mouth. While generally better tolerated than chemotherapy, this radiopharmaceutical treatment may lower blood cell counts and requires radiation safety protocols for 14 days. Most side effects are manageable and subside within 1.5 weeks.</p> <ul> <li><strong>Systemic fatigue:</strong> Post-infusion exhaustion typically lasts from a few days to 1.5 weeks.</li> <li><strong>Xerostomia:</strong> Salivary gland radiation exposure can cause persistent dry mouth or taste changes.</li> <li><strong>Hematologic impact:</strong> Temporary drops in red blood cells may cause mild, self-resolving anemia.</li> <li><strong>Gastrointestinal distress:</strong> Reduced appetite and nausea are most frequent during the first week.</li> </ul> <p><strong>Bookimed Expert Insight:</strong> Data from leading Spanish centers like Centro Médico Teknon shows that xerostomia is the most frequent long-term concern. Patients can mitigate this by using sugar-free lozenges and maintaining high hydration levels immediately after their infusion. Clinics in Barcelona and Madrid often combine these supportive measures with regular blood monitoring to track recovery.</p> <p><strong>Patient Consensus:</strong> Many patients find that immediate fatigue is the most significant hurdle. It is common to experience a temporary loss of appetite, which usually improves by the second week.</p>"},{"q":"Where can I receive Lutetium-177 therapy in Spain?","a":"<p>Lutetium-177 therapy is available in Spain at specialized oncology centers in Madrid and Barcelona. Top-tier facilities like Centro Médico Teknon and HM Sanchinarro offer radioligand therapy. Treatment costs range from _op_830_price_from_ to _op_830_price_to_, saving patients approximately _price_percent_discount_% compared to United States prices.</p> <ul> <li><strong>Available locations:</strong> Madrid and Barcelona host major JCI-accredited nuclear medicine departments.</li> <li><strong>Leading clinics:</strong> Centro Médico Teknon and Hospital Universitario HM Madrid provide advanced oncology.</li> <li><strong>Typical costs:</strong> Therapy sessions generally range from _op_830_price_from_ to _op_830_price_to_.</li> <li><strong>Treatment types:</strong> Clinics offer both Lu-177 PSMA and alternative Actinium-225 PSMA radioligand therapies.</li> </ul> <p><strong>Bookimed Expert Insight:</strong> Spain presents a unique paradox in nuclear medicine. While Novartis manufactures Pluvicto locally, routine clinical access remains highly restricted. Patients often face mandatory video consultations before approval. High-volume centers like HM Madrid serve over 2.3 million outpatients annually. This infrastructure supports complex systemic radionuclide therapy for international patients.</p> <p><strong>Patient Consensus:</strong> Verification is essential before traveling. Local production does not guarantee immediate clinical availability. Many patients inquire about compassionate use programs directly through manufacturers. Practical reality requires confirming specific department protocols for radioligand therapy.</p>"},{"q":"How is Lutetium-177 therapy performed?","a":"<p>Lutetium-177 therapy is a targeted radioligand treatment administered via intravenous infusion to destroy metastatic cancer cells. Surgeons in Spain utilize Pluvicto or custom radiopharmaceuticals in Joint Commission International accredited facilities to treat advanced neuroendocrine tumors and prostate cancer under strict radiation safety protocols.</p> <ul> <li><strong>Administration method:</strong> The drug enters the bloodstream through a standard intravenous drip.</li> <li><strong>Treatment cycle:</strong> Patients typically receive 6 infusions spaced roughly 6 to 8 weeks apart.</li> <li><strong>Session duration:</strong> The infusion requires approximately 20 minutes followed by brief clinical observation.</li> <li><strong>Controlled setting:</strong> Therapy occurs in specialized units to monitor radiation and manage side effects.</li> </ul> <p><strong>Bookimed Expert Insight:</strong> While many countries offer this as a standard outpatient service, top Spanish facilities like Centro Médico Teknon or Hospital Universitario HM Madrid integrate it into comprehensive oncology programs. These centers treat over 10,000 patients annually. This high volume ensures medical teams are exceptionally skilled at managing the specific week-long recovery period where fatigue and dry mouth are common.</p> <p><strong>Patient Consensus:</strong> Patients emphasize the importance of confirming availability directly with oncologists due to limited local access. Many appreciate the manageable recovery timeline, noting that most side effects typically subside within 7 days.</p>"},{"q":"Can international patients receive Lutetium-177 therapy in Spain?","a":"<p>International patients can receive Lutetium-177 therapy in Spain at JCI-accredited facilities like Centro Médico Teknon. Specialized centers in Madrid and Barcelona offer Lu-177 PSMA and DOTATATE treatments. These clinics adhere to European Union nuclear medicine regulations while providing dedicated international patient support teams for medical visa logistics.</p> <ul> <li><strong>Available locations:</strong> Specialized oncology centers operate in major hubs including Madrid and Barcelona.</li> <li><strong>Clinical standards:</strong> Hospitals maintain Joint Commission International (JCI) and European Foundation for Quality Management accreditation.</li> <li><strong>Patient logistics:</strong> Clinics require recent PET-CT scans and a medical visa for travel.</li> <li><strong>Cost profile:</strong> Treatment ranges from _op_830_price_from_ to _op_830_price_to_ per cycle.</li> </ul> <p><strong>Bookimed Expert Insight:</strong> Spain ranks highly for Lutetium-177 because hospitals like HM Madrid and Centro Médico Teknon integrate nuclear medicine with comprehensive oncology departments. While the treatment costs significantly less than the US average of _price_compare_US_average_, the real value is the established infrastructure. These hospitals manage over 10,000 patients annually, ensuring high proficiency in handling radiopharmaceuticals.</p> <p><strong>Patient Consensus:</strong> Patients report that securing a medical visa is a primary logistical priority. Most recommend confirming specific hospital requirements for private insurance or financial proof before traveling for therapy.</p>"}],"h2":[{"text":"How Much Does Lutetium-177 therapy Cost in Spain?","kind":"content"},{"text":"Your Benefits and Guarantees with Bookimed","kind":"content"},{"text":"Your personal Bookimed medical coordinator","kind":"content"},{"text":"Discover the Best Lutetium-177 therapy Clinics in Spain: 3 Verified Options and Prices","kind":"content"},{"text":"Lutetium-177 therapy Overview in Spain","kind":"content"},{"text":"Our Doctors","kind":"content"},{"text":"Video Stories from Bookimed Patients","kind":"ui"},{"text":"Reviews about Bookimed: Discover Patients' Insights","kind":"ui"},{"text":"Related Articles","kind":"ui"},{"text":"Share this content","kind":"ui"},{"text":"Fast Facts about Lutetium-177 therapy","kind":"content"},{"text":"FAQ about Lutetium-177 therapy in Spain","kind":"content"},{"text":"Get a free consultation","kind":"ui"}]},"placeholders":{"price_from":"{{price_from}}","clinics_count":"{{clinics_count}}","cities_count":"{{cities_count}}","savings_pct":"{{savings_pct}}","data_date":"{{data_date}}"},"legal":{"restricted_markets":{"status":"missing","reason":"not_collected"}},"conflicts":[]}